Daiken Medical Co (TSE:7775) 3-Year EBITDA Growth Rate : -3.60% (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Daiken Medical Co 3-Year EBITDA Growth Rate?

Daiken Medical Co's EBITDA per Share for the three months ended in Dec. 2023 was 円17.02.

During the past 12 months, Daiken Medical Co's average EBITDA Per Share Growth Rate was 9.00% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -3.60% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -2.80% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -2.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Daiken Medical Co was 12.10% per year. The lowest was -15.20% per year. And the median was 0.90% per year.

Competitive Comparison of Daiken Medical Co's 3-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, Daiken Medical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Daiken Medical Co's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Daiken Medical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Daiken Medical Co's 3-Year EBITDA Growth Rate falls into.

Daiken Medical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Daiken Medical Co (TSE:7775) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Daiken Medical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Daiken Medical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Daiken Medical Co (TSE:7775) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Daiken Medical Co Ltd (TSE:7775) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-6-1, Dosho-Machi, Chuo-Ku, Osaka, JPN, 541-0045

Website

http://www.daiken-iki.co.jp

Daiken Medical Co Ltd manufactures and sells medical equipment. The product line includes - Coopdech syrinjector, Coopdech Syrinjector PCA device, Coopdech Balloonjector, Coopdech Endobronchial blocker tube, Coopdech double-lumen endobronchial tube, Fit fix suction container system, Wet disinfectant mat, and others.

Daiken Medical Co (TSE:7775) Headlines

No Headlines